Stockreport

How the Narrative Surrounding Sangamo Therapeutics Is Shifting After New Regulatory and Valuation Signals [Yahoo! Finance]

Sangamo Therapeutics, Inc.  (SGMO) 
Last sangamo therapeutics, inc. earnings: 2/28 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.sangamo.com
PDF Behind this shift, a slightly reduced discount rate of 7.31% alongside stronger long term assumptions for revenue growth reflects a blend of greater regulatory clarity, [Read more]